Senior Consultant
Division of Surgery & Surgical Oncology
Senior Consultant
Hepato-pancreato-biliary and Transplant Surgery
Pierce Chow graduated MBBS and PhD from the National University of Singapore. He trained in General Surgery at the Singapore General Hospital and won the Chapter of Surgeons Gold Medal at the conjoint M.Med(Surgery)/FRCS(Edinburgh) examination. Following advanced surgical training in Singapore, he completed a clinical Fellowship in Hepato-Pancreato-Biliary Surgery and Liver Transplantation with Professor Russell Strong in Australia and was subsequently appointed Consultant Surgeon at the Singapore General Hospital.
Pierce is currently tenured professor at the Duke-NUS Medical School and director of the Comprehensive Liver Cancer Clinic at the National Cancer Center Singapore. He is an NMRC funded Senior Clinician Scientist and Principal Investigator (PI) of the NMRC National Flagship Program in Liver Cancer, the PLANet study. He is also funded by BMRC to conduct, in collaboration with industry, the prospective cohort study of patients at high risk of developing liver cancer (ELEGANCE). He has authored more than 300 peer-reviewed papers and has published in the Lancet, Cell, JCO, Nature Cancer, Journal of Hepatology, Gut and other top journals.
Besides clinical work and research, Pierce is also very active in medical education. He is the inaugural and current director of the PhD Program in Clinical and Translational Science at the Duke-NUS Medical School Singapore. He was the inaugural director of the pre-clinical Normal Body course in the same medical school and the founding president of the College of Clinician Scientists at the Academy of Medicine Singapore.
Pierce is Protocol Chair of the Asia-Pacific Hepatocellular Carcinoma (AHCC) Trials Group and has conducted 12 prospective multi-center clinical studies that has enrolled more than 5000 patients from 62 sites across 17 countries and territories in the Asia-Pacific. In recognition of his outstanding work in clinical and translational liver cancer research, Pierce was conferred the NMRC Outstanding Clinician Scientist Award in 2012 and the NMRC Singapore Translational Research (STaR) Investigator Award in 2025. In 2023, he was inducted into Duke-NUS Medical School’s Hall of Master Academic Clinicians.
Selected Publications of the past 5 years